Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature review.

Date publication

décembre 2019

Journal

Autoimmunity reviews

Auteurs

Membres identifiés du Cancéropôle Est :
Dr D'AVENI-PINEY Maud

Tous les auteurs :
Roupie AL, de Boysson H, Thietart S, Carrat F, Seguier J, Terriou L, Versini M, Queyrel V, Groh M, Benhamou Y, Maurier F, Decaux O, d'Aveni M, Rossignol J, Galland J, Solary E, Willems L, Schleinitz N, Ades L, Dellal A, Samson M, Aouba A, Fenaux P, Fain O, Mekinian A,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31838164

Résumé

Myelodysplastic syndromes (MDS) and MDS/myeloproliferative neoplasms (MDS/MPN) can be associated with giant cell arteritis (GCA). In this nationwide study by the "French Network of dysimmune disorders associated with hemopathies" (MINHEMON) the objective was to evaluate characteristics, treatment and outcome of GCA MDS-MDS/MPN.

Mots clés

Giant cell arteritis, Myelodysplastic syndrome, Outcome

Référence

Autoimmun Rev. 2019 Dec 12;:102446